Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: David C. Mares, MD
Catching alpha-1 antitrypsin deficiency (AATD) early in a chronic obstructive pulmonary disease (COPD) patient could help clinicians to act in a preventative way for that individual patient, and hopefully, change their disease process. So could increasing the importance of screening in our practices be a better solution? Tune in with Dr. Charles Turck as he speaks with Dr. David Mares, specializes in Adult Pulmonology and Critical Care in Anderson, Indiana.

Click here to order free AlphaID™ screening kits to rule out Alpha-1 deficiency in your patients.